Source: Annual Congress 2011 - Tuberculosis in pregnancy and childhood
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
R. Ahmed, D. Gascoyne- Binzi, S. Moffitt, T. Collyns, J. Watson (Leeds, United Kingdom). Interferon-gamma release assays (IGRA) for latent tuberculosis infection (LTBI) in children. Eur Respir J 2011; 38: Suppl. 55, 4980

Member's Comments

No comment yet.

Related content which might interest you: Interferon-γ release assays (IGRA) vs. tuberculin skin testing (TST) for detecting latent tuberculosis infection (LTBI) in chronic hemodialysis (CH) patients Source: Annual Congress 2008 - New tools in tuberculosis diagnosis Year: 2008 Interferon-γ release assays (IGRA) for detecting latent tuberculosis (LTBI) after lung transplantation (LTX) Source: Annual Congress 2008 - Lung and bone marrow transplantation: miscellaneous Year: 2008 Quantiferon-TB Gold in tube assay for detecting latent TB infection in immigrants and TB contacts Source: Annual Congress 2013 –Tuberculosis and latent tuberculosis infection: diagnosis and treatment Year: 2013 The value of tuberculin skin test (TST) and interferon – gamma release assay (IGRA) in the diagnosis of latent tuberculosis infection (LTBI) according to age group Source: Annual Congress 2010 - Immune responses for the diagnosis of tuberculosis Year: 2010 QuantiFERON-TB GIT (QFT-GIT) vs TST in diagnosis of latent tuberculosis (TB) infection (LTBI) in household TB contacts in poland Source: Annual Congress 2009 - Tuberculosis contact screening Year: 2009 QFT-GIT vs TST in diagnosis of latent tuberculosis infection (LTBI) in Poland Source: Annual Congress 2011 - Tuberculin skin tests, interferon-gamma release assays and beyond Year: 2011 What is latent tuberculosis infection (LTBI)? Source: Annual Congress 2009 - Microbial colonisation or latency: a foot in the door to respiratory infections Year: 2009 The value of interferon-gamma releasing assays (IGRA) determining latent tuberculosis infection in renal transplant candidates Source: International Congress 2016 – Active and latent tuberculosis: biomarkers Year: 2016 Comparison of tuberculin skin test (TST) and QuantiFERON-TB-Gold in Tube (QFT) in the diagnosis of latent tuberculosis infection (LTBI) in a prospective community study of contacts of tuberculosis (TB) Source: Annual Congress 2010 - What is new in the diagnosis of tuberculosis? Year: 2010 Comparison of a T-cell-based assay with tuberculin skin testing (TST) for diagnosis of latent tuberculosis infection (LTBI) in contact-tracing procedures Source: Annual Congress 2005 - Diagnosis of tuberculosis and LTBI Year: 2005 Concordance between tuberculin skin testing and interferon-gamma release assays in diagnosis of latent tuberculosis infection among HIV-infected individuals Source: Annual Congress 2012 - Tuberculosis and immunologic assays Year: 2012 Interferon-gamma release assays for the diagnosis of latent Mycobacterium tuberculosis infection Source: Eur Respir J 2011; 38: 1237-1238 Year: 2011 The role of quantiferon tuberculosis gold test (Q) in diagnosing active tuberculosis (TB) and latent tuberculosis infection (LTI) in children Source: Annual Congress 2008 - New tests and methods to diagnose tuberculosis infection and disease and to monitor treatment Year: 2008 QuantiFERON-TB Gold in-tube test for diagnosis of latent tuberculosis (TB) infection among immunocompromised adults Source: Annual Congress 2013 –Immunological diagnosis of tuberculosis and latent tuberculosis infection Year: 2013 Additional analysis of antigen-specific Interleukin-2 release does not improve the performance of IGRAs for the differentiation of different states of mycobacterium tuberculosis infection Source: International Congress 2014 – Future frontiers in the diagnosis of Mycobacterium tuberculosis infection Year: 2014 Clinical evaluation of interferon-gamma release assay (IGRA) in patients with nontuberculous mycobacterial disease Source: Annual Congress 2012 - Non-tuberculous and tuberculous mycobacterial infections: from epidemiology to clinical findings Year: 2012 Contribution of the T-SPOT.TB assay for differentiating active versus latent tuberculosis infection (LTBI) Source: Annual Congress 2006 - New methods to diagnose tuberculosis infection Year: 2006 Cost-effectiveness of interferon-γ release assay testing for the treatment of latent tuberculosis Source: Eur Respir J 2007; 30: 321-332 Year: 2007 Diagnostics of the latent TBC infection (LTBI) activity in children Source: Annual Congress 2011 - Tuberculosis in pregnancy and childhood Year: 2011 Modulation of whole-blood IGRA response in patients with latent TB infection during treatment Source: International Congress 2018 – Tuberculosis transmission and screening strategies Year: 2018